Search

everythinglearnresearchcommunity

for

Search:↓

Testosterone can slow down hair growth when combined with certain cells from bald scalps, and this effect can be blocked by an androgen receptor blocker.

Higher androgen levels do not cause baldness in men.

The document concludes that managing female hyperandrogenism requires a combination of identifying the cause, lifestyle changes, medication, and cosmetic treatments.

A new, less toxic and more efficient method to create the anti-baldness compound RU58841 was developed in 2014.

The mouse model suggests male pattern baldness may be due to an enzyme increasing DHT and higher androgen receptor levels in hair follicles.

The androgen receptor's shape-changing ability helps it function but can lead to cancer treatment resistance.

Certain gene variations are linked to a higher risk of severe acne, suggesting a genetic influence on the condition.

The document explains how certain drugs block hormones to treat cancers like breast and prostate cancer.

Hormones significantly affect hair growth and loss, with potential for new treatments.

Hormones and genetics affect hair growth and patterns, with some changes reversible and others not.

The hHa7 gene is regulated by androgens in certain body hair, not scalp hair.

Estrogen and androgen signals control synaptic changes in rat brains.

Researchers successfully made new compounds for hormone level tests, but one attempt led to an unexpected product, correcting a past error.

Testosterone can slow hair growth in adult monkeys, but a blocker called RU 58841 can counteract this and potentially help hair regrow.

Different fields of expertise must work together to better understand hair growth and create effective hair loss treatments.

Older obese women with PCOS have higher cardiovascular and metabolic risks despite lower androgen levels.

A new method creates unique chemical structures that could improve drug discovery.

Teen hair loss common in boys, linked to family history and mild symptoms.

New pregnane derivatives were more effective than finasteride at inhibiting a key enzyme for male pattern baldness.

Hairless gene not strongly linked to baldness.

5α reductase type 2 enzyme mutation and oxidative stress may increase androgenetic alopecia risk in Egyptians.

Androgenic alopecia causes hair follicle degradation and skin restructuring, but some hair elements remain.

The -866G/A polymorphism in the UCP2 gene is not linked to polycystic ovary syndrome.

Chronic exposure to sunlight may worsen male pattern baldness and protecting the scalp from the sun could slow it down.

Finasteride effectively blocks rat enzymes, but with varying methods and strength.

New compounds called benzoquinolinones may treat conditions linked to excess DHT.

A49T gene variant linked to higher prostate cancer risk, lower hormone levels, and slightly reduced balding risk.

Certain defective glucocorticoid receptor mutants move faster inside cell nuclei and work less effectively.

Using 17-hydroxyprogesterone levels to diagnose nonclassic congenital adrenal hyperplasia can result in many incorrect diagnoses.

Rice bran extract might help prevent hair loss.